KLOW – GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg)

Description

A four-component co-formulation supplied for controlled research environments. Suitable for studies involving peptide characterization and method development in model systems.


Composition

  • GHK-Cu: 50 mg

  • KPV: 10 mg

  • BPC-157: 10 mg

  • TB-500 (Thymosin Beta 4): 10 mg

  • Appearance: lyophilized powder in a sealed research vial


Research Focus (non-clinical)

  • Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems

  • Assay development, including chromatographic separation of four co-formulated peptides

  • Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions

  • Method documentation for HPLC/LC-MS identity and purity assessments


Documentation

  • Lot-specific COA available

  • Batch and lot traceability


Important Notice

  • For research use only

  • Not for human consumption

  • Not intended to diagnose, treat, cure, or prevent any disease


Quality & Manufacturing

  • Lot-specific COA

  • Lyophilized for transit stability; batch traceable

  • Tamper-evident seal; lot & test date on each vial

  • No MOQ for online orders

  • Bulk orders for physical locations start at 25-unit minimum